During the past decade, University of Michigan Congenital Heart Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Congenital Heart Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Pediatric Heart Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan Congenital Heart Center" are "Single Ventricle Heart Disease" (2 trials), "Functional Single Ventricle Heart Disease" (1 trials), "Orthotopic Heart Transplant" (1 trials), "Pulmonary Regurgitation" (1 trials) and "Pulmonary Stenosis" (1 trials). Many other conditions were trialed in "University of Michigan Congenital Heart Center" in a lesser frequency.

Most popular intervention types in "University of Michigan Congenital Heart Center" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Udenafil" (3 trials), "Adenosine" (1 trials), "MZ101" (1 trials), "Placebo" (1 trials) and "Repair of RV-PA Conduit Disruption" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan Congenital Heart Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "University of Michigan Congenital Heart Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Michigan Congenital Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan Congenital Heart Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".